Validation of FGF-23 as a Biomarker for Phosphorus Homeostasis in Hemodialysis Patients
Dina Hilal Ibrahim Hilal;
Abstract
Chronic kidney disease is a public health epidemic that affects millions of people worldwide. Presence of CKD predisposes individuals to high risks of ESRD, cardiovascular disease, and premature death.
Disordered phosphate homeostasis with elevated circulating levels of fibroblast growth factor- 23 is an early and pervasive complication of CKD. CKD is likely the most common cause of chronically elevated FGF23 levels, and the clinical condition in which levels are most markedly elevated.
Disordered phosphate homeostasis with elevated circulating levels of fibroblast growth factor- 23 is an early and pervasive complication of CKD. CKD is likely the most common cause of chronically elevated FGF23 levels, and the clinical condition in which levels are most markedly elevated.
Other data
| Title | Validation of FGF-23 as a Biomarker for Phosphorus Homeostasis in Hemodialysis Patients | Other Titles | صلاحية عامل نمو الفيبروبلاست-23 كدلالة بيولوجية على مدى توازن الفوسفور فى مرضى الفشل الكلوى | Authors | Dina Hilal Ibrahim Hilal | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.